News

Pediatric PH a growing burden, national study finds

View on the News

Likely ‘the tip of the iceberg’ on this issue

It is likely that data from this report represent “the tip of the iceberg” regarding the true impact of PH on hospitalizations, resource utilization, costs, and clinical outcomes. The actual health care costs and resource needs of pediatric PH, as with other chronic diseases, are limited by a lack of data linking inpatient with outpatient care, in which frequent clinic appointments and diagnostic evaluations are essential for improving outcomes well beyond inpatient care alone. The impact of pediatric PH also may be underestimated in these data because the diagnosis of PH and its evaluation are complex, and the role of PH may not be recognized in some clinical settings by health care providers. Despite growing recognition and awareness of PH in many settings, such as prematurity, Down syndrome, obstructive sleep apnea, sickle cell disease, oncologic disorders, chronic lung diseases, liver disease, and others, PH is often a “hidden” contributor to morbidities and outcomes.

More research is needed to best define an optimal PH center for children, but it is likely that this goal will require creation of interdisciplinary teams of cardiologists, pulmonologists, intensivists, neonatologists, and other subspecialists, along with approaches that enhance collaboration between centers.

Dr. Steven H. Abman and Dr. D. Dunbar Ivy are with the pediatric heart lung center in the department of pediatrics at the University of Colorado at Denver Anschutz Medical Center and Children’s Hospital Colorado, Aurora. These remarks were excerpted from a commentary that appeared online in Pediatrics on July 6, 2015 (doi/10.1542/peds.2015-1697) that is supported in part by a grant from the National Heart, Lung, and Blood Institute and the National Institutes of Health. The authors reported having no relevant financial disclosures.


 

FROM PEDIATRICS

References

Between 1997 and 2006, the proportion of hospitalizations in the United States for pediatric pulmonary hypertension doubled, from 1 in 1,000 discharges for the condition in 1997 to 1 in 500 in 2006, a national retrospective cohort study found.

“These results have practice and policy implications at the institutional, state, and national levels, particularly in the face of increasing pressure to restrain costs while caring for a population with increasingly complex medical needs,” researchers led by Dr. Bryan G. Maxwell reported online June 6, 2015 in Pediatrics (doi/10.1542/peds.2014-3834).

Dr. Maxwell of the departments of anesthesiology and critical care medicine at Johns Hopkins University, Baltimore, Md., and his associates examined data on pediatric pulmonary hypertension (PH) hospitalizations between 1997 and 2006 from the Kids’ Inpatient Database, which is part of the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality.

Of the estimated 43 million pediatric discharges that occurred between 1997 and 2006, 0.13% were for PH, and discharges for the condition increased over the study period, from 1 in 500 in 1997 to 1 in 1,000 in 2006 (P less than .0001). During the same time period, inflation-adjusted national hospital charges for PH hospitalizations increased from $926 million to 3.12 billion (P = .0003).

The researchers also found that the increase in PH discharges was most pronounced between 2006 and 2012, and that most PH hospitalizations did not occur in dedicated children’s hospitals. The overall mortality of patients discharged with PH was 5.9%, and steadily improved between 1997 and 2012 (P less than .0001).

Dr. Maxwell and his associates acknowledged certain limitations of the study, including the fact that the Kids’ Inpatient Database does not provide longitudinal data on patients with PH over time or on outpatient care, and that ICD-9-CM codes “do not permit accurate identification of subgroups of patients with PH in a way that is consistent with the most current schemata for categorizing PH.”

Despite such limitations, they concluded that the current study “is useful in demonstrating the burgeoning number and nature of pediatric PH hospitalizations and the implications of these trends for resource utilization and public policy.”

The researchers reported having no relevant financial disclosures.

dbrunk@frontlinemedcom.com

Recommended Reading

FDA approves cangrelor, an intravenous antiplatelet drug
MDedge Cardiology
Half of Hispanics unaware of their high cholesterol
MDedge Cardiology
Idarucizumab reverses dabigatran’s anticoagulant effects
MDedge Cardiology
Angina drug ranolazine lowers glucose in type 2 diabetes
MDedge Cardiology
Paclitaxel-coated balloon boosts femoropopliteal angioplasty patency
MDedge Cardiology
Two U.S. transcatheter valve approvals reshape TAVR
MDedge Cardiology
CVD becomes second-largest cause of death in U.K.
MDedge Cardiology
Older MI patients missing out on ICDs
MDedge Cardiology
Cheaper generics keep statin expenditures in check
MDedge Cardiology
SVS: Four easy preop variables predict mortality in ruptured AAAs
MDedge Cardiology